Financial Performance - Turkcell Group's revenue increased by 12.5% year-over-year to TRY 53.022 billion[58] - EBITDA grew by 14.8% year-over-year to TRY 23.086 billion, with an EBITDA margin of 43.5%, a 0.9 percentage point increase[58] - Net income from continuing operations increased by 36.8% year-over-year to TRY 4.388 billion[5] Subscriber Growth & ARPU - Postpaid net additions reached 816,000, a record high in 5.5 years[5] - Mobile ARPU increased by 9.8% year-over-year to TRY 352.5[5] - Residential Fiber ARPU increased by 17.5% year-over-year to TRY 418.2[5] Business Segments - Techfin revenue grew by 23.1%[6] - Data Center & Cloud revenue grew by 53.2%[6] - Digital Business Services revenue increased by 39% year-over-year, reaching TRY 4.930 billion[30] Fixed Broadband - Turkcell Fiber saw a net addition of 4,000 subscribers quarter-over-quarter[5] - 12-month contract share in residential fixed broadband reached 87%[23] Techfin - Loan portfolio reached TRY 7.3 billion[33] - Total transaction volume increased by 75% year-over-year to TRY 38.8 billion[33]

Production & Outlook - 2025 consolidated silver production is projected to be 450万-520万盎司[16] - 2025 consolidated gold production is projected to be 31000-34000盎司[16] - H1 2025 silver equivalent production reached 440万盎司，包括来自Kolpa的贱金属产量[22,23] Kolpa Mine Acquisition & Performance - Kolpa矿的收购预计将使Endeavour的年产量增加约510万盎司银当量[30] - Kolpa在2024年生产了200万盎司银，19800吨铅，12600吨锌和500吨铜（合计510万盎司银当量）[27,36] - Q2 2025 Kolpa生产了380638盎司银，3503吨铅，2316吨锌和58吨铜，总计805032盎司银当量[32] Terronera Project - Terronera项目预计年产400万盎司银和38000盎司黄金，即700万盎司银当量，矿山寿命为10年[71] - 截至2025年6月30日，Terronera项目的资本支出约为33800万美元[67] - Terronera项目的概略寿命期内平均品位为374克/吨银当量[70] Financial Highlights - 截至2025年8月12日，市值约为17亿美元[119] - 截至2025年8月12日，现金头寸为5250万美元[119] Resources & Reserves - Guanacevi的探明储量为20万吨，银当量品位为506克/吨，含有330万盎司银当量[44] - Bolanitos的探明储量为8万吨，银当量品位为259克/吨，含有60万盎司银当量[56] - Terronera的概略储量为740万吨，银当量品位为374克/吨，含有8880万盎司银当量[66]

Company Overview and Strategy - CIM Group, a real estate and infrastructure firm, manages CMCT and owns approximately 68% of its stock as of June 30, 2025[8, 12, 151] - CMCT focuses on acquiring, owning, operating, and developing creative office and premier multifamily assets in vibrant communities[15] - The company aims to strengthen its balance sheet and liquidity by extending debt maturities and financing growth initiatives[22, 23] - CMCT's strategy is designed to benefit from the trend toward a more cohesive work/live lifestyle[33] Portfolio Composition and Performance - CMCT's office portfolio is 701% leased in aggregate, consisting of 12 Class A and creative office properties[21] - The company owns 4 premier Class A multifamily properties with 764 total units and has 1 premier Class A multifamily property under development with 36 units[18] - As of June 30, 2025, the total office portfolio's rentable square footage is 1299518 with an overall occupancy rate of 681%[60] - The total multifamily portfolio consists of 764 units with an occupancy rate of 834% and an annualized rent of $18793 thousand[66] Financial Activities and Debt Management - In April 2025, CMCT fully repaid and retired its recourse credit facility after completing 4 new financings across 7 properties[30] - As of June 30, 2025, the company's total debt stood at $5407 million, with a mix of fixed and variable rate mortgages[166] - The company's fixed-rate mortgages payable range from 414% to 741% interest, while variable rate mortgages are based on SOFR plus a margin[166]

Financial Performance & Restructuring - ProPhase Labs sold Pharmaloz Manufacturing for $23.6 million[11] - The company shut down the genomics laboratory, saving over $6 million per year[11] - ProPhase Labs is targeting over $50 million in net near-term cash recovery from COVID-19 receivables through an initiative with Crown Medical Collections[13, 15, 94] BE-Smart Esophageal Cancer Diagnostic - The BE-Smart test achieved greater than a 95% technical success rate in a key validation study, confirming its ability to reliably detect biomarkers[36, 95] - The total potential addressable market for the BE-Smart test is estimated at ~$7 billion - $14 billion[27] - The annual incidence change of Esophageal Adenocarcinoma (EAC) was 766.67% higher in 2017 compared to 1973[25] DNA Complete & Nebula Genomics - DNA Complete was launched on November 4, 2024, offering whole genome sequencing[11, 47] - DNA Complete analyzes virtually 100% of DNA, compared to less than 1% analyzed by typical DNA Ancestry tests[47] Equivir Dietary Supplement - Preliminary results from Equivir clinical trials showed that 37.7% of patients in the Equivir group acquired a viral infection versus 62.3% in the placebo group[78] - After 4 days of illness, only 3% of the Equivir group still had mild symptoms vs 55% in the placebo group[79]

Financial Performance - Q2 2025 adjusted EBITDA reached $245 million[9], while free cash flow was $88 million[9] - The company achieved a record trailing twelve-month EBITDA of $996 million[17] - Net debt to adjusted EBITDA ratio improved to 0.4x[17] - LTM Free Cash Flow reached $413 million[18] - Cash as of Q2'25 was $626 million[18] - Net Debt as of Q2'25 was $434 million[18] Operational Performance - Q2 2025 copper production was 30.0 kt[12] - Gold production in Q2 2025 was 56.3 koz[12] - Cash cost for copper production in Q2 2025 was negative $0.02 per pound[9] Copper World Project & Mitsubishi JV - Mitsubishi Corporation will invest $600 million for a 30% interest in the Copper World Joint Venture[42] - The average analyst consensus net asset value (NAV) estimate for 100% of Copper World is approximately $1.16 billion as of August 12, 2025[47] - Hudbay's remaining equity contribution to the Copper World project is estimated at approximately $200 million[60] - The initial capital expenditure for the Copper World project is $1.5 billion[70]

Production Updates & Roadmap - Hyliion delivered the second early adopter unit to the U S Navy[10] - The company is nearing completion of two more KARNO Power Modules, one for UL Certification and the other for a commercial customer[10] - Hyliion plans to deliver 10 early adopter customer units in 2025, with full product commercialization shifting into 2026[14] - The company continues to build an inventory of printed components for KARNO Power Modules[14] Financial Performance & Outlook - In Q2 2025, Hyliion reported $1.5 million in R&D service revenue and a gross margin of $0.1 million[19, 22] - The net loss for Q2 2025 was $13.4 million[19] - Year-to-date R&D service revenue reached $2.0 million, with a gross margin of $0.1 million[19] - The net loss year-to-date was $30.7 million[19] - Hyliion anticipates total cash use of approximately $65 million for the full year 2025[26, 28] Strategic Initiatives - A 30% Investment Tax Credit has been established for businesses deploying linear electric motors or fuel cells[5] - Hyliion sees up to a $1 billion KARNO Power Modules opportunity in Saudi Arabia[17]

NASDAQ:VRME Protect your brand. Grow your business. Second Quarter 2025 Investor Conference Call August 13, 2025 01 Welcome & Introductions Operations and Strategic Update 02 Financial Review 03 Q&A 04 Closing Remarks 05 Forward Looking Statements NASDAQ:VRME In addition to historical information, this presentation contains statements relating to revenue opportunities, anticipated revenue, profitability of the combined company, future business, financial performance, future catalysts and future events or de ...

Financial Performance - Net sales increased by 26.9% to $123123 thousand in Q2 2025 compared to $97015 thousand in Q2 2024, with organic growth of 11.3%[42] - Gross profit increased by 39.3% in Q2 2025 due to a positive mix of higher margin products, value-based pricing, and optimized productivity[42] - Adjusted EBITDA increased by 34.5% to $47118 thousand in Q2 2025 compared to $35031 thousand in Q2 2024, with an Adjusted EBITDA Margin of 38.3% versus 36.1%[42] - Net income increased from $7641 thousand in Q2 2024 to $16713 thousand in Q2 2025[42] - The company expects to deliver 1%-3% of revenue growth annually through new product introductions[19] Portfolio and Market - In 2024, Commercial end market accounted for 42% of revenue, Defense 24%, Non-Aviation 7%, and Business Jet & General Aviation 27%[24] - Aftermarket accounted for 55% of 2024 revenue, while OEM accounted for 45%[24] - The A320 Family and 737 Family platforms represent 7% and 6% of annual sales respectively[36] - YTD Q2 2025, total sales increased by 11% compared to YTD Q2 2024, with Commercial up 13% and Defense up 24%[40] Outlook - The revised full year 2025 outlook projects net sales between $486 million and $494 million, and adjusted EBITDA between $184 million and $187 million[52] - The revised full year 2025 outlook projects adjusted EBITDA Margin of approximately 38.0%[52]

Second Quarter 2025 Performance - Revenue grew by 31% year-over-year, reaching $921.5 million in the second quarter of 2025, driven by strong performance in the E&M segment[29] - Backlog increased by 24% year-over-year, reaching $30 billion, with E&M backlog up 24% and T&D backlog up 21%[30, 34] - EBITDA increased by 36% year-over-year, reaching $842 million in the second quarter of 2025, driven by strong revenue growth and margin expansion[31, 34] - EBITDA margin expanded by 30 basis points to 91% in the second quarter of 2025[10, 33] Segment Performance - E&M revenues increased by 42% in the second quarter of 2025, driven by continued momentum in data center work, reaching $7136 million[13, 37] - E&M EBITDA increased by 53% with a 70 bps margin expansion[13, 39] - T&D revenues increased by 3% in the second quarter of 2025, driven by growth in both transportation and utility end markets, reaching $2124 million[13, 40] - T&D EBITDA increased by 19%, driven by a 200 bps margin expansion[13, 43] Financial Position and Guidance - The company had $274 million in total unrestricted cash and cash equivalents and revolver availability as of June 30, 2025, with a net leverage of 08x[14, 52] - The company is raising its 2025 revenue guidance to $33 billion - $34 billion and EBITDA guidance to $240 million - $255 million[53]

August 13, 2025 Q4 F25 $1,002 $1,064 $1,109 $1,197 $1,127 $1,346 $1,413 $1,449 Q1 Q2 Q3 Q4 Total Company Sales F24 F25 $1,013 $1,074 $1,120 $1,208 $1,139 $1,358 $1,425 $1,462 Q1 Q2 Q3 Q4 Total Revenues F24 F25 * Chili's, Maggiano's, and Company sales restated to include F23 accounting change. Q4 FOOD COST HIGHER DUE TO UNFAVORABLE MENU MIX SAFE HARBOR STATEMENT During these presentations, and in response to your questions, certain items may be discussed which are not based entirely on historical facts. Any ...